$0.00
The CMV antigenemia assay was developed using a cocktail of two monoclonal antibodies (C10/C11) directed against CMV lower matrix protein pp65. The assay uses the C10/C11 cocktail in an indirect immunofluorescence staining of cytospin preparations of peripheral blood leukocytes. The first step in the CMV Brite™ Turbo method involves direct lysis of peripheral blood erythrocytes. Following lysis, the leukocytes are cytocentrifuged onto a slide, fixed and permeabilized to allow subsequent detection of CMV pp65 antigen. The presence of the CMV pp65 antigen is detected by the C10/C11 antibody cocktail and visualized by means of a specific secondary FITC-labeled antibody. CMVantigen-positive leukocytes exhibit homogeneous yellow-green polylobate nuclear staining when observed using a fluorescence microscope. The number of CMV antigen-positive cells is counted per duplicate stain. The whole procedure can be performed in approximately 2 hours.
Reagents for 110 tests including 5 control slides.
Reagent A | Erythrocyte Lysing Solution – Ammonium chloride solution containing <0.1% sodium azide. (10x). (Dilute before use in demineralized water). 200 ml |
---|---|
Reagent B | Fixative Solution – Formaldehyde, in PBS, containing < 0.1% sodium azide. (Dilute before use in PBS). (5x) 290 ml |
Reagent C | Permeabilization Solution – Igepal Ca-630 and Newborn Calf Serum in PBS containing < 0.1% sodium azide.(5x) (Dilute before use in PBS). 290 ml |
Reagent D | Monoclonal antibody C10/C11 (IgG1/IgG1) against CMV lower matrix protein pp65 containing < 0.1% sodium azide. (Ready to use) 4.0 ml |
Reagent E | FITC-conjugated sheep anti-mouse Immunoglobulins – with Evans Blue containing < 0.1% sodium azide. (Ready to use) 4.0 ml |
Control Slides | CMV Antigenemia Control Microscope Slides – Control slide in a sealed pouch with desiccant. (Ready to use). 5 slides |